Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessCompaniesGranules gets US FDA nod for anti-inflammatory drug

    Granules gets US FDA nod for anti-inflammatory drug

    "US FDA has approved Abbreviated New Drug Application (ANDA) for Ibuprofen tablets USP, 200 mg (OTC) filed by Granules India Ltd," the company said in a BSE filing.

    October 13, 2016 / 13:17 IST
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      Pharma firm Granules today said it has received approval from the US health regulator for anti-inflammatory drug Ibuprofen tablets, in the US market.

      "US FDA has approved Abbreviated New Drug Application (ANDA) for Ibuprofen tablets USP, 200 mg (OTC) filed by Granules India Ltd," the company said in a BSE filing.

      The approved ANDA is the bio-equivalent to the reference listed drug product (RLD), Motrin IB Tablets, 200 mg, of Johnson & Johnson Consumer, Inc, it added.

      Shares of Granules India Ltd were trading 0.62 percent higher at Rs 121 on BSE.

      first published: Oct 13, 2016 12:24 pm

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347